Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma

Journal of Cancer

Volumn 8, Issue 4, 2017, Pages 523-530

  Yu, Jianjun ^a,b   Liu, Yan ^a   Guo, Can ^a,c   Zhang, Shanshan ^c   Gong, Zhaojian ^a,b,c   Tang, Yanyan ^a   Yang, Liting ^a   He, Yi ^a   Lian, Yu ^a   Li, Xiayu ^a   Deng, Hao ^a   Liao, Qianjin ^a,c   Li, Xiaoling ^a,c   Li, Yong ^a,c,d   Li, Guiyuan ^a,c   Zeng, Zhaoyang ^a,c   Xiong, Wei ^a,c   Yang, Xinming ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Long intergenic non coding RNA 152 (LINC00152); Long non coding RNA (LncRNA); Metastasis; Prognosis; Tongue squamous cell carcinoma (TSCC)

Indexed keywords

LONG UNTRANSLATED RNA;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; OVERALL SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS EPITHELIUM; TONGUE CARCINOMA; TUMOR BIOPSY; UPREGULATION;

EID: 85013943206     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.17510     Document Type: Article

References (60)

1. Kimple AJ, Welch CM, Zevallos JP, et al. Oral cavity squamous cell carcinoma-an overview. Oral Health Dent Manag. 2014; 13: 877-82.
2. Schwam ZG, Judson BL. Improved prognosis for patients with oral cavity squamous cell carcinoma: Analysis of the National Cancer Database 1998-2006. Oral Oncol. 2016; 52: 45-51.
3. Bagan J, Sarrion G, Jimenez Y. Oral cancer: clinical features. Oral Oncol. 2010; 46: 414-7.
4. Sciubba JJ. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol. 2001; 2: 239-51.
5. Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333: 1157-60.
6. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011; 11: 9-22.
7. Liang F, Li Q, Li X, et al. TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer. Int J Oncol. 2016; 49: 1046-56.
8. Li Q, Chen P, Zeng Z, et al. Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. Tumour Biol. 2016; 37: 12503-12.
9. Liao Q, Zeng Z, Guo X, et al. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene. 2014; 33: 2098-109.
10. Song Y, Li X, Zeng Z, et al. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1. Oncotarget. 2016; 7: 36783-99.
11. Xiong W, Zeng ZY, Xia JH, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res. 2004; 64: 1972-4.
12. Zeng Z, Zhou Y, Zhang W, et al. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med. 2006; 8: 156-60.
13. Zhou Y, Liao Q, Li X, et al. HYOU1, Regulated by LPLUNC1, Is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis. J Cancer. 2016; 7: 367-76.
14. Tu CF, Qi P, Li XY, et al. Tumor Heterogeneity: The Challenge of Precision Medicine. Prog Biochem Biophys. 2015; 42: 881-90.
15. Yu ZY, Song YL, Gong ZJ, et al. The Mechanism and Tumorigenesis of Oncogenic DNA Virus Integration. Prog Biochem Biophys. 2014; 41: 324-31.
16. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008; 359: 1143-54.
17. Gong Z, Zhang S, Zhang W, et al. Long non-coding RNAs in cancer. Sci China Life Sci. 2012; 55: 1120-4.
18. Bo H, Gong Z, Zhang W, et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget. 2015; 6: 20404-18.
19. Gong Z, Zhang S, Zeng Z, et al. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS One. 2014; 9: e110674.
20. He B, Li W, Wu Y, et al. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. Cell Death Dis. 2016; 7: e2353.
21. Wang Y, Xue D, Li Y, et al. The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature. J Cancer. 2016; 7: 991-1001.
22. Zeng Z, Bo H, Gong Z, et al. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis. Tumour Biol. 2016; 37: 729-37.
23. Zeng Z, Fan S, Zhang X, et al. Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma. Clin Transl Oncol. 2016; 18: 206-11.
24. Zhang W, Huang C, Gong Z, et al. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol. 2013; 44: 545-54.
25. Yu J, Liu Y, Gong Z, et al. Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma. Oncotarget. 2017; doi: 10.18632/oncotarget.14200.
26. Lian Y, Li XY, Tang YY, et al. Long Non-coding RNAs Function as Competing Endogenous RNAs to Regulate Cancer Progression. Prog Biochem Biophys. 2016; 43: 219-25.
27. Li YW, Wang YM, Zhang XY, et al. Progress of Long Noncoding RNA HOTAIR in Human Cancer. Prog Biochem Biophys. 2015; 42: 228-35.
28. Tang K, Wei F, Bo H, et al. Cloning and Functional Characterization of a Novel Long Non-coding RNA Gene Associated With Hepatocellular Carcinoma. Prog Biochem Biophys. 2014; 41: 153-62.
29. Gong ZJ, Huang HB, Xu K, et al. Advances in microRNAs and TP53 Gene Regulatory Network. Prog Biochem Biophys. 2012; 39: 1133-44.
30. Ye H, Yu T, Temam S, et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics. 2008; 9: 69.
31. Chen C, Mendez E, Houck J, et al. Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2152-62.
32. Zhang W, Fan S, Zou G, et al. Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma. Tumour Biol. 2015; 36: 675-83.
33. Xiong W, Wu X, Starnes S, et al. An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood. 2008; 112: 4235-46.
34. Liang F, Xu K, Gong ZJ, et al. ChIP-seq: a New Technique for Genome-wide Profiling of Protein-DNA Interaction. Prog Biochem Biophys. 2013; 40: 216-27.
35. Huang HB, Liang F, Xiong W, et al. Bioinformatics Accelerates Drug Repositioning. Prog Biochem Biophys. 2012; 39: 35-44.
36. Xiao K, Yu Z, Li X, et al. Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji Cells. J Cancer. 2016; 7: 214-24.
37. Zeng Z, Huang H, Huang L, et al. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci China Life Sci. 2014; 57: 315-26.
38. Duan Z, Zheng H, Xu S, et al. Activation of the Ig Ialpha1 promoter by the transcription factor Ets-1 triggers Ig Ialpha1-Calpha1 germline transcription in epithelial cancer cells. Cell Mol Immunol. 2014; 11: 197-205.
39. Hu D, Duan Z, Li M, et al. Heterogeneity of aberrant immunoglobulin expression in cancer cells. Cell Mol Immunol. 2011; 8: 479-85.
40. Hu D, Zheng H, Liu H, et al. Immunoglobulin expression and its biological significance in cancer cells. Cell Mol Immunol. 2008; 5: 319-24.
41. Li M, Zheng H, Duan Z, et al. Promotion of cell proliferation and inhibition of ADCC by cancerous immunoglobulin expressed in cancer cell lines. Cell Mol Immunol. 2012; 9: 54-61.
42. Zhao R, Liu Y, Wang H, et al. BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-small ka, CyrillicB signaling pathway. Cell Mol Immunol. 2016;
43. Yang Y, Zhou H, Yang Y, et al. Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NFkappaB and MAPKs signaling pathways. Mol Immunol. 2007; 44: 984-92.
44. Zheng H, Li M, Ren W, et al. Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Mol Immunol. 2007; 44: 2221-7.
45. Zhang W, Zeng Z, Fan S, et al. Evaluation of the prognostic value of TGF-beta superfamily type I receptor and TGF-beta type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays. J Mol Histol. 2012; 43: 297-306.
46. Zeng Z, Huang H, Zhang W, et al. Nasopharyngeal carcinoma: advances in genomics and molecular genetics. Sci China Life Sci. 2011; 54: 966-75.
47. Zeng ZY, Zhou YH, Zhang WL, et al. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol. 2007; 38: 120-33.
48. Zeng Z, Zhou Y, Xiong W, et al. Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol. 2007; 133: 71-81.
49. Yang L, Tang Y, He Y, et al. High Expression of LINC01420 indicates an unfavorable prognosis and modulates cell migration and invasion in nasopharyngeal carcinoma. J Cancer. 2017; 8:97-103.
50. Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013; 52: 101-12.
51. Han D, Gao X, Wang M, et al. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Oncotarget. 2016; 7: 22159-73.
52. Chu M, Yuan W, Wu S, et al. Quantitative assessment of polymorphisms in H19 lncRNA and cancer risk: a meta-analysis of 13, 392 cases and 18, 893 controls. Oncotarget. 2016; doi: 10.18632/oncotarget.12530.
53. Yan L, Zhou J, Gao Y, et al. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. Oncogene. 2015; 34: 3076-84.
54. el-Naggar AK, Lai S, Tucker SA, et al. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. Oncogene. 1999; 18: 7063-9.
55. Esteves LI, Javaroni AC, Nishimoto IN, et al. DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas? Mol Carcinog. 2005; 44: 102-10.
56. Li YC, Chang JT, Chiu C, et al. Areca nut contributes to oral malignancy through facilitating the conversion of cancer stem cells. Mol Carcinog. 2016; 55: 1012-23.
57. Majumder KR, Karmakar R, Alam MM, et al. Carcinoma Tongue-Clinicopathological Presentation. Mymensingh Med J. 2015; 24: 787-93.
58. Ji J, Tang J, Deng L, et al. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. Oncotarget. 2015; 6: 42813-24.
59. Zhao J, Liu Y, Zhang W, et al. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer. Cell Cycle. 2015; 14: 3112-23.
60. Li J, Wang X, Tang J, et al. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma. Cell Physiol Biochem. 2015; 37: 687-96.